scispace - formally typeset
Open AccessJournal ArticleDOI

Association of Comorbid Conditions and Mortality in Hemodialysis Patients in Europe, Japan, and the United States: The Dialysis Outcomes and Practice Patterns Study (DOPPS)

Reads0
Chats0
TLDR
Variability in demographic and comorbid conditions (as identified by dialysis facilities) explains only part of the differences in mortality between dialysis centers, both for comparisons made across continents and within the US.
Abstract
Mortality rates among hemodialysis patients vary greatly across regions. Representative databases containing extensive profiles of patient characteristics and outcomes are lacking. The Dialysis Outcomes and Practice Patterns Study (DOPPS) is a prospective, observational study of representative samples of hemodialysis patients in France, Germany, Italy, Japan, Spain, the United Kingdom, and the United States (US) that captures extensive data relating to patient characteristics, prescriptions, laboratory values, practice patterns, and outcomes. This report describes the case-mix features and mortality among 16,720 patients followed up to 5 yr. The crude 1-yr mortality rates were 6.6% in Japan, 15.6% in Europe, and 21.7% in the US. After adjusting for age, gender, race, and 25 comorbid conditions, the relative risk (RR) of mortality was 2.84 (P < 0.0001) for Europe compared with Japan (reference group) and was 3.78 (P < 0.0001) for the US compared with Japan. The adjusted RR of mortality for the US versus Europe was 1.33 (P < 0.0001). For most comorbid diseases, prevalence was highest in the US, where the mean age (60.5 +/- 15.5 yr) was also highest. Older age and comorbidities were associated with increased risk of death (except for hypertension, which carried a multivariate RR of mortality of 0.74 [P < 0.0001]). Variability in demographic and comorbid conditions (as identified by dialysis facilities) explains only part of the differences in mortality between dialysis centers, both for comparisons made across continents and within the US. Adjustments for the observed variability will allow study of association between practice patterns and outcomes.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal Article

K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients.

TL;DR: Cardiovascular Disease in Dialysis Patients Tables: An Overview of Epidemiology of Cardiovascular disease in Children and Work Group Members and Foreword.
Journal ArticleDOI

Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study

TL;DR: This study expands the understanding of the relationship between altered mineral metabolism and outcomes and identifies several potential opportunities for improved practice in this area.
Journal ArticleDOI

KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease

TL;DR: This study presents baseline characteristics of hemodialysis patients with chronic HCV infection receiving IFN-based regimens and evidence profile for treatment regimens for pegylated-interferon monotherapy and ribavirin in kidney transplant recipients with chronicHCV infection.
Journal ArticleDOI

Predictors of Early Mortality among Incident US Hemodialysis Patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS)

TL;DR: Inadequate predialysis nephrology care was strongly associated with mortality during this period, highlighting the potential benefits of contact with a nephrologist at least 1 mo before HD initiation.
References
More filters
Journal ArticleDOI

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin.

TL;DR: In patients with clinically evident congestive heart failure or ischemic heart disease who are receiving hemodialysis, administration of epoetin to raise their hematocrit to 42 percent is not recommended.
Journal ArticleDOI

Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients.

TL;DR: The strikingly elevated mortality risk with lowpredialysis systolic BP suggests that low predialysis BP needs to be viewed with great concern and avoided where possible, and greater attention to postdialysis hypertension is suggested.
Journal ArticleDOI

Five-Year Survival for End-Stage Renal Disease Patients in the United States, Europe, and Japan, 1982 to 1987

TL;DR: Analysis of 5-year survival for new end-stage renal disease patients accepted for renal replacement therapy between 1982 and 1987 in the United States, Europe, and Japan showed that the US patients were older and more likely to be diabetic than the patients in either EDTA or Japan.
Related Papers (5)